Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Biomolecules
|
May 24, 2024
Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial Cancer
Ziyi Zhao, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology
|
March 31, 2024
High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines
Xiaochang Shen, Jiandong Wang, Boer Deng, et al.
American Journal of Cancer Research
|
December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer
Allison Staley, Katherine Tucker, Yajie Yin, et al.
Journal of Hematology & Oncology
|
September 23, 2016
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
Lu Zhang, Jianjun Han, Amanda L Jackson, et al.
Frontiers in Pharmacology
|
December 19, 2024
<i>Asparagus officinalis</i> L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer
Ziwei Fang, Weimin Kong, Ziyi Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 28, 2019
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
Ileana C Cuevas, Subhransu S Sahoo, Ashwani Kumar, et al.
Environmental Research
|
June 23, 2025
Chronic PFAS exposure induces chemotherapy resistance by promoting mitochondria-related alterations in ovarian cancer cells
Brittany P Rickard, Lauren A Sapienza-Lundie, Marta Overchuk, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
Gina Song, Teresa K Tarrant, Taylor F White, et al.
Biorxiv : the Preprint Server for Biology
|
February 19, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer
Ziyi Zhao, Jiandong Wang, Weimin Kong, et al.
Journal of Cancer Research and Clinical Oncology
|
August 25, 2022
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
Xin Zhang, Jiandong Wang, Yali Fan, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Biomolecules
|
May 24, 2024
Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial Cancer
Ziyi Zhao, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology
|
March 31, 2024
High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines
Xiaochang Shen, Jiandong Wang, Boer Deng, et al.
American Journal of Cancer Research
|
December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer
Allison Staley, Katherine Tucker, Yajie Yin, et al.
Journal of Hematology & Oncology
|
September 23, 2016
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
Lu Zhang, Jianjun Han, Amanda L Jackson, et al.
Frontiers in Pharmacology
|
December 19, 2024
<i>Asparagus officinalis</i> L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer
Ziwei Fang, Weimin Kong, Ziyi Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 28, 2019
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
Ileana C Cuevas, Subhransu S Sahoo, Ashwani Kumar, et al.
Environmental Research
|
June 23, 2025
Chronic PFAS exposure induces chemotherapy resistance by promoting mitochondria-related alterations in ovarian cancer cells
Brittany P Rickard, Lauren A Sapienza-Lundie, Marta Overchuk, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
Gina Song, Teresa K Tarrant, Taylor F White, et al.
Biorxiv : the Preprint Server for Biology
|
February 19, 2024
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer
Ziyi Zhao, Jiandong Wang, Weimin Kong, et al.
Journal of Cancer Research and Clinical Oncology
|
August 25, 2022
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
Xin Zhang, Jiandong Wang, Yali Fan, et al.
Page
of 10